-
HOBt: Reaction Control from Coupling to Discovery
2026-09-03
HOBt (1-Hydroxybenzotriazole) is more than a peptide coupling additive: it can shape reaction selectivity, analytical strategy, and medicinal-chemistry route design. This article interprets its role through a glucagon receptor antagonist synthesis and translates that evidence into practical workflow decisions.
-
MG-262: Reversible Proteasome Inhibitor
2026-09-03
MG-262, also called Z-Leu-Leu-Leu-B(OH)2, is a cell-permeable, reversible inhibitor of proteasome chymotryptic activity. It supports proteasome inhibition assay design, apoptosis research, and studies of protein homeostasis when interpreted alongside appropriate pathway controls.
-
gamma-Glu-Cys (γ-Glu-Cys) Workflow Guide
2026-09-02
gamma-Glu-Cys (γ-Glu-Cys) provides a defined, soluble intermediate for glutathione synthetase enzyme assays, glutathione metabolism research, and selected peptide workflows. It is intended for controlled scientific use with freshly prepared solutions, not for diagnostic, clinical, or medical applications.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-09-02
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based assays. It is intended for research workflows such as in situ hybridization and Northern blot hybridization, not for diagnostic, clinical, or therapeutic use.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-09-01
The Tricine-SDS-PAGE Gel Preparation Kit is designed to improve separation of low-molecular-weight proteins and peptides, including targets in the 1–10 kDa range that can be difficult to resolve by conventional Tris-SDS-PAGE. It is intended for research protein electrophoresis and should not be used for diagnostic, clinical, or medical applications.
-
MK 0893 Glucagon Receptor Antagonist Workflows
2026-09-01
Build stronger GCGR assays with MK 0893, a competitive, reversible glucagon receptor antagonist that connects receptor pharmacology to cAMP signaling and metabolic phenotyping. This guide emphasizes practical dosing, assay controls, formulation, selectivity testing, and troubleshooting for type 2 diabetes research.
-
HyperScribe T7 High Yield RNA Synthesis Kit
2026-08-31
This scenario-driven guide explains how SKU K1047 can standardize RNA inputs for cell viability, proliferation, and cytotoxicity workflows. It covers T7 RNA polymerase transcription, modified and labeled transcripts, protocol planning, data interpretation, and practical vendor selection.
-
Magnetite–CNC Assembly for Magnetic Hyperthermia
2026-08-30
The reference study clarifies how sulfated and TEMPO-oxidized cellulose nanocrystals bind Fe3O4 through different interfacial mechanisms, linking surface chemistry to dispersion, magnetization, and heating performance. Its comparative design provides a framework for engineering biocompatible magnetic nanocomposites, while its cytotoxicity results support further—but not yet clinical—evaluation of these materials.
-
Nutlin-3a: MDM2 Inhibitor for p53 Studies
2026-08-29
Nutlin-3a is a small-molecule MDM2 inhibitor that activates p53 signaling by blocking the MDM2 TP53-binding pocket. Its research uses include p53 pathway activation, cell cycle arrest, apoptosis induction, and mechanistic cancer research, while its activity remains dependent on cellular context and experimental conditions.
-
Atrial Slow Conduction in Persistent Atrial Fibrillation
2026-08-29
Lange and colleagues showed that premature stimulation expands pre-existing slow-conduction regions in atria remodeled by persistent atrial fibrillation, rather than primarily creating new regions. Their optical-mapping strategy links pacing conditions, propagation direction, and spatial conduction heterogeneity, providing a useful framework for studying arrhythmogenic conduction reserve.
-
Baicalin Reactivates Visual Plasticity in Adult Amblyopia
2026-08-28
A 2026 NeuroImage study shows that Baicalin can reopen ocular dominance plasticity in adult amblyopic mice, with 10 mg/kg treatment enabling recovery that was not observed at 5 mg/kg or with a Scutellaria water extract. Imaging, electrophysiology, molecular analyses, and muscimol blockade collectively implicate reduced GABAergic inhibition in the restoration of visual cortical flexibility.
-
From Nanocarrier Delivery to Translational Readouts
2026-08-28
A mechanistic and strategic analysis of iRGD-functionalized red blood cell membrane nanocarriers for neuroblastoma photodynamic therapy, showing how rigorous fluorescence and tissue-based readouts can convert promising delivery biology into translational evidence. The article also explains where the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody fits into a reproducible validation workflow.
-
Protease Inhibitor Cocktail for Plant Extracts
2026-08-27
Discover how a Protease Inhibitor Cocktail can preserve plant proteins while improving interpretation of phosphorylation-sensitive assays. This guide connects extract handling with SHP2 conformational biology to provide a more rigorous, assay-centered workflow.
-
2-Thio-dCTP in Reliable Cell Assays
2026-08-27
Learn how 2-Thio-dCTP (SKU B8104) can support controlled DNA synthesis, site-specific DNA modification, and mechanistic interpretation alongside cell viability, proliferation, and cytotoxicity workflows. The article separates validated product characteristics from laboratory recommendations and explains how chromosome-stability findings should—and should not—be connected to nucleotide-based assays.
-
Y-27632 Dihydrochloride Stem Cell Workflows
2026-08-26
Y-27632 dihydrochloride is a selective ROCK inhibitor for improving post-dissociation cell recovery, dissecting cytoskeletal remodeling, and testing invasion-related phenotypes. This workflow connects transient ROCK inhibition with the long-term myogenic engraftment model reported for human pluripotent stem cell-derived progenitors, while separating evidence-based findings from practical assay recommendations.
454 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page